Author: Rowland, L. P.; Shneider, N. A.
Description: Charcot described amyotrophic lateral sclerosis (ALS) in 1874. Despite progress, this creeping paralysis, known colloquially as Lou Gehrig’s disease, is still not visibly affected by available therapies. However, advances in genetics have accelerated the pace of ALS research in the past decade, promising more effective treatment.
Subject headings: Amyotrophic Lateral Sclerosis; Environment; Genetic Predisposition to Disease; Humans; Motor Neurons; Mutation; Suicide, Assisted; Superoxide Dismutase; Superoxide Dismutase-1; ALS
Publication year: 2001
Journal or book title: The New England Journal of Medicine
Volume: 344
Issue: 22
Pages: 1688-1700
Find the full text: https://www.nejm.org/doi/full/10.1056/NEJM200105313442207
Find more like this one (cited by): https://scholar.google.com/scholar?cites=9284854301440066519&as_sdt=1000005&sciodt=0,16&hl=en
Serial number: 3729